Krause L
Augenklinik, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin.
Ophthalmologe. 2005 Apr;102(4):329-34. doi: 10.1007/s00347-004-1166-2.
Adamantiades-Behcet's disease (ABD) is a chronic recurrent vasculitis whose aetiology is still unclear. The first description goes back to B. Adamantiades und H. Behcet. The disease mainly occurs in Mediterranean, Middle and Far Eastern countries. However, it is not limited to these regions and can be found worldwide, and, as a result of increasing human mobility, is steadily becoming more significant. Clinical findings reveal recurrent oral and/or genital ulcers, arthritis and skin involvement in the form of erythema nodosum and superficial thrombophlebitis. Relapsing ocular involvement is one of the major manifestations in ABD and can be found in 60-80% of patients, resulting in retinal vasculitis, neuropathy or panuveitis. Eye involvement can lead to blindness in the affected eye in 20-50% of cases. Steroids, cyclosporin A und azathioprin are available to treat affected eyes. Studies of new treatment modalities including interferon-alpha or TNF antibodies are under way.
白塞病(ABD)是一种病因尚不明确的慢性复发性血管炎。首次描述可追溯到B. 阿达曼蒂亚德斯和H. 白塞。该病主要发生在地中海、中东和远东国家。然而,它并不局限于这些地区,在全球范围内都能发现,并且由于人类流动性的增加,其重要性正日益凸显。临床发现包括复发性口腔和/或生殖器溃疡、关节炎以及以结节性红斑和浅表血栓性静脉炎形式出现的皮肤受累。复发性眼部受累是白塞病的主要表现之一,60 - 80%的患者会出现,导致视网膜血管炎、神经病变或全葡萄膜炎。20 - 50%的病例中,眼部受累可导致患眼失明。可使用类固醇、环孢素A和硫唑嘌呤来治疗受累眼睛。包括干扰素-α或肿瘤坏死因子抗体在内的新治疗方法的研究正在进行中。